EP2846778
ORAL SOLID DOSAGE FORMULATION OF 1,1-DIMETHYLETHYL [(1S)-1-{[(2S,4R)-4-(7-CHLORO-4METHOXYISOQUINOLIN-1-YLOXY)-2-({(1R,2S)-1-[(CYCLOPROPYLSULFONYL)CARBAMOYL]-2-ETHENYLCYCLOPROPYL}CARBAMOYL)PYRROLIDIN-1-YL]CARBONYL}-2,2-DIMETHYLPROPYL]CARBAMATE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
3.5.2013EP published:
25.4.2018EP application number:
13722251.9
EPO information:
European Patent Register
Max expiry date:
2.5.2033
Title:
ORAL SOLID DOSAGE FORMULATION OF 1,1-DIMETHYLETHYL [(1S)-1-{[(2S,4R)-4-(7-CHLORO-4METHOXYISOQUINOLIN-1-YLOXY)-2-({(1R,2S)-1-[(CYCLOPROPYLSULFONYL)CARBAMOYL]-2-ETHENYLCYCLOPROPYL}CARBAMOYL)PYRROLIDIN-1-YL]CARBONYL}-2,2-DIMETHYLPROPYL]CARBAMATE
Timeline
Today
3.5.2013EP application
25.4.2018EP Publication
Owner
Name:
Bristol-Myers Squibb Holdings IrelandAddress:
Hinterbergstrasse 16, Steinhausen, CH
Inventor
Name:
HAMEY, RhyeAddress:
New Brunswick, New Jersey, US
Name:
PANDEY, PreetanshuAddress:
New Brunswick, New Jersey, US
Name:
BINDRA, Dilbir S.Address:
New Brunswick, New Jersey, US
Name:
VEMAVARAPU, ChandraAddress:
Pennington, New Jersey, US
Name:
PERRONE, Robert KevinAddress:
New Brunswick, New Jersey, US
Priority
Number:
201261643486 PDate:
7.5.2012Country:
US
Classification
Categories:
A61K 9/20, A61K 31/4709, A61P 31/14